Axel Mark News

Axel Mark: change report

Jan 9 03:12 ET

Axel Mark: Acquired a license to manufacture and sell Class II medical devices and in vitro diagnostic pharmaceuticals from the wholly owned subsidiary Accel Medica Co., Ltd.

Jan 7 01:05 ET

Axel Mark: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Jan 6 01:30 ET

Axel Mark: Change report.

Jan 5 19:33 ET

Axel Mark: Corporate Governance Report 2024/12/27

Dec 27, 2024 02:14 ET

Axel Mark: Explanatory materials on business plans and growth potential

Dec 27, 2024 01:30 ET

Axel Mark: Progress based on plans aimed at complying with listing maintenance standards

Dec 27, 2024 01:30 ET

Axel Mark: Notice Concerning Mass Exercise of the 29th Stock Acquisition Rights (with Exercise Price Amendment Clauses) Issued by Third-Party Allotment

Dec 25, 2024 01:30 ET

Axel Mark: change report

Dec 24, 2024 19:05 ET

Axel Mark: Interim report.

Dec 23, 2024 01:39 ET

Axel Mark: Notice of conclusion of a basic agreement on share transfer agreements involving changes in subsidiaries, etc.

Dec 23, 2024 01:30 ET

Axel Mark: Articles of Incorporation 2024/12/20

Dec 20, 2024 03:03 ET

Axel Mark: Extraordinary Report

Dec 20, 2024 02:11 ET

Axel Mark: Internal Control Report - 32nd Term (2023/10/01 - 2024/09/30)

Dec 20, 2024 01:25 ET

Axel Mark: Confirmation

Dec 20, 2024 01:24 ET

Axel Mark: Securities report - 32nd period (2023/10/01 - 2024/09/30)

Dec 20, 2024 01:23 ET

Axel Mark: Interim report.

Dec 17, 2024 01:57 ET

Axel Mark: Notice of conclusion of a basic agreement on share transfer agreements involving changes in subsidiaries, etc.

Dec 17, 2024 01:30 ET

Axel Mark: New banner template “experiential creative” officially launched on ad distribution platform “AdRoute”

Dec 10, 2024 00:00 ET

Axel Mark: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Dec 6, 2024 00:29 ET